[SHINSA]Questions and Answers on Clinical Trial Consultations for Pediatric Drug Development posted.
Safety Classified by Officially
Links to major regulatory information of pediatric and orphan drugs.
October 23, 2026 PMDA Pediatric Drug Working Group
February 27, 2026 PSB Notification No. 0227-1
February 27, 2026 PSB/PED Notification No. 0227-2
February 27, 2026 PSB/PED Notification No. 0227-8
February 27, 2026 PSB/PED Notification No. 0227-9
November 27, 2025 HPB/RDD Notification No. 1127-1・PED/PSB Notification No. 1127-3
March 21, 2025 PMDA/CPE Notification No. 1618・PMDA/CRS Notification No. 15
June 30, 2020 PSEHB/PED Administrative Notice
This is an extract. The publication continues at the source.
Source: Pharmaceuticals and Medical Devices Agency (Japan) website. Licence
Read the original at the source: https://www.pmda.go.jp/english/review-services/regulatory-info/0012.html
Officially imported this from Pharmaceuticals and Medical Devices Agency (Japan)’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Pharmaceuticals and Medical Devices Agency (Japan) — imported from official source
- Official source
- https://www.pmda.go.jp/rss_008.xml RSS
- Imported
- November 13, 2026 00:33
- Versions
- 1 recorded
- Identity
-
https://www.pmda.go.jp/english/review-services/regulatory-info/0012.html